AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glygiv GP 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Pensia Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glygiv GP 1mg/500mg Tablet

Diabetic patients may find relief with the dual-action Glygiv GP 1mg/500mg tablet, a medication categorized as an anti-diabetic agent. This formulation combines two active components to manage type 2 diabetes mellitus in adults, effectively regulating blood glucose. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication forms one element of a comprehensive diabetes management plan, incorporating a balanced diet, exercise, and weight management as recommended by your healthcare provider. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring, along with blood cell and liver function tests, will be necessary under your physician's guidance.

Uses of Glygiv GP 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glygiv GP 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glygiv GP 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glygiv GP 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glygiv GP 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glygiv GP 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Glygiv GP 1mg/500mg Tablet works:

Glygiv GP 1mg/500mg tablets combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glygiv GP 1mg/500mg Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glygiv GP 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Lactation and Glygiv GP 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glygiv GP 1mg/500mg tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. A physician's consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Glygiv GP 1mg/500mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Glygiv GP 1mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glygiv GP 1mg/500mg Tablet :

Should you forget to take your Glygiv GP 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glygiv GP 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glygiv GP 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glygiv GP 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glygiv GP 1mg/500mg Tablets and seek immediate medical attention.
Glygiv GP 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glygiv GP 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glygiv GP 1mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glygiv GP 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glygiv GP 1mg/500mg Tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glygiv GP 1mg/500mg Table...
94
MRP 115
18% off